Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Versant Ventures is a premier healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of life-changing companies. The firm invests across the healthcare sector, with a primary focus on biopharmaceuticals, medical devices, and healthcare technology. Versant has a global presence and actively partners with entrepreneurs from discovery and company formation through clinical development and commercialization, aiming to translate groundbreaking science into impactful therapies and solutions for patients.
Serves as a central hub for investment activities, portfolio company management, deal sourcing, and networking within the prominent U.S. West Coast biotech ecosystem.
Located in the One Sansome Street skyscraper (Citigroup Center), a prominent Class A office building in San Francisco's Financial District, offering modern office facilities and panoramic city views.
A dynamic, collaborative, and science-driven environment focused on identifying and nurturing groundbreaking healthcare innovations. The culture emphasizes deep scientific and clinical diligence, hands-on company building, and a long-term commitment to portfolio companies.
The San Francisco location provides direct access to one of the world's leading biotech clusters, including world-class research institutions, a dense network of startups, experienced talent, and co-investors.
Versant Ventures operates with a significant global footprint, with established offices and teams in key innovation hubs across North America (USA and Canada) and Europe (Switzerland and France). This international presence enables the firm to source a diverse range of investment opportunities, build globally competitive companies by accessing talent and resources worldwide, and leverage its Discovery Engines for de novo company creation. Functions supported globally include deal sourcing, scientific and clinical due diligence, investment execution, hands-on portfolio company building and support, and fostering international collaborations within the life sciences industry.
One Sansome Street, Suite 3650
San Francisco
CA
USA
Address: Aeschenvorstadt 56, 4051 Basel, Switzerland
Focuses on identifying and nurturing European life sciences innovation, company creation (particularly via its discovery engines), and providing access to the European market and talent.
Address: 7 World Trade Center, 250 Greenwich Street, 46th Floor, New York, NY 10007, USA
Supports deal origination, investment execution, and collaboration with East Coast-based entrepreneurs, institutions, and the financial community.
Address: MaRS Centre, West Tower, 661 University Avenue, Suite 465, Toronto, ON M5G 1M1, Canada
To foster and fund Canadian biotech innovation, particularly in areas of novel therapeutics and platform technologies, often in partnership with local academic institutions.
Address: 9920 Pacific Heights Blvd, Suite 150, San Diego, CA 92121, USA
Taps into San Diego's rich pool of scientific talent and biotech startups, particularly in genomics, oncology, immunology, and cell therapy.
Address: #400 – 6190 Agronomy Road, Vancouver, BC V6T 1Z3, Canada
Drives early-stage drug discovery and company creation through a dedicated research team embedded within a leading Canadian university.
Address: Undisclosed specific street address, generally located in Paris.
To access and invest in French innovation, particularly in areas like gene therapy, immuno-oncology, and rare diseases, and to support the growth of French biotech companies on a global scale.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Versant Ventures' leadership includes:
Versant Ventures has been backed by several prominent investors over the years, including:
Over the past 12 months (mid-2023 to mid-2024), Versant Ventures has actively strengthened its team through strategic promotions and new hires, particularly at the Operating Partner and Venture Partner levels. These appointments enhance the firm's capabilities in company building and investment expertise. No high-profile executive departures have been publicly announced during this period.
Discover the tools Versant Ventures uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Email formats for Versant Ventures most commonly use the [first_initial][last]@[domain] pattern. While other formats might exist, this is a widely observed structure for professionals at the firm.
[first_initial][last]@versantventures.com
Format
jdoe@versantventures.com
Example
75%
Success rate
BioSpace • March 13, 2024
Versant Ventures announced the promotion of Laura Brege, Ph.D., to operating partner. Dr. Brege will leverage her extensive biopharma leadership experience to provide strategic and operational support to Versant’s portfolio companies....more
PR Newswire / Versant Ventures • February 20, 2024
Abivax (Euronext Paris and Nasdaq: ABVX), a clinical-stage biotech company developing novel therapeutics that modulate the immune system to treat patients with chronic inflammatory diseases, and a Versant Ventures portfolio company, announced the successful closing of its U.S. Initial Public Offering on Nasdaq, raising approximately $203 million in gross proceeds....more
GlobeNewswire / Versant Ventures • January 8, 2024
Two Versant Ventures-incubated companies, Altumira Bio and Ares Immunotherapies, announced their merger to form Abdera Therapeutics, a new precision oncology company focused on developing next-generation targeted radiopharmaceuticals. Abdera launched with a combined $142 million Series A and B financing led by Versant Ventures....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Versant Ventures, are just a search away.